Literature DB >> 9217575

Hepatitis C-associated osteosclerosis after blood transfusion.

M P Whyte1, C A Reasner.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9217575     DOI： 10.1016/s0002-9343(97)89507-1

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  7 in total

1.  A case of hepatitis C-associated osteosclerosis that was improved with the combination therapy of peginterferon alfa-2b and ribavirin.

Authors:  Satoshi Shakado; Yuko Akehi; Kaoru Yotsumoto; Atsushi Fukunaga; Shizuka Kuno; Takashi Tanaka; Kunitoshi Sakurai; Hideyuki Iwashita; Shuichi Ueda; Genryu Hirano; Keiji Yokoyama; Daisuke Morihara; Shinya Nishizawa; Masaharu Sakamoto; Akira Anan; Yasuaki Takeyama; Makoto Irie; Kaoru Iwata; Tetsuro Sohda; Shotaro Sakisaka
Journal:  Clin J Gastroenterol       Date:  2011-06-10

2.  Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults.

Authors:  S Khosla; A A Hassoun; B K Baker; F Liu; N N Zein; M P Whyte; C A Reasner; T B Nippoldt; R D Tiegs; R L Hintz; C A Conover
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

3.  An uncommon cause of acquired osteosclerosis in adults: hepatitis C-associated osteosclerosis.

Authors:  Narendranath Epperla; Fergus E McKiernan
Journal:  Skeletal Radiol       Date:  2014-04-10       Impact factor: 2.199

4.  OPG/RANKL system imbalance in a case of hepatitis C-associated osteosclerosis: the pathogenetic key?

Authors:  Paolo Manganelli; Nicola Giuliani; Pieranna Fietta; Cristina Mancini; Mirca Lazzaretti; Angela Pollini; Federico Quaini; Mario Pedrazzoni
Journal:  Clin Rheumatol       Date:  2004-12-04       Impact factor: 2.980

5.  Hepatitis C-associated osteosclerosis (HCAO): report of a new case with involvement of the OPG/RANKL system.

Authors:  C E Fiore; S Riccobene; R Mangiafico; F Santoro; P Pennisi
Journal:  Osteoporos Int       Date:  2005-06-28       Impact factor: 4.507

6.  Hepatitis C-Associated Osteosclerosis: Improvement After Treatment with Sofosbuvir, Daclatasvir, and Ibandronate: Case Report and Literature Review.

Authors:  Maria Carolina de Camargo Vieira; Wagner Rodrigo Brida Gonçalves; Ricardo Ayello Guerra; Fabiana Siroma Callegaro; Marise Lazaretti-Castro; Sergio Setsuo Maeda
Journal:  Calcif Tissue Int       Date:  2021-02-22       Impact factor: 4.333

Review 7.  Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management.

Authors:  Celia L Gregson; Sarah A Hardcastle; Cyrus Cooper; Jonathan H Tobias
Journal:  Rheumatology (Oxford)       Date:  2013-02-27       Impact factor: 7.580
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.